AI assistant
INSMED Inc — Director's Dealing 2025
Jun 12, 2025
30150_dirs_2025-06-12_799da77f-2884-4f44-b12b-bfed8dd5c3ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-06-10
Reporting Person: Bonstein Sara (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-06-10 | Common Stock | M | 24150 | $18.95 | Acquired | 137438 | Direct |
| 2025-06-10 | Common Stock | M | 23740 | $17.07 | Acquired | 161178 | Direct |
| 2025-06-10 | Common Stock | S | 7277 | $87.12 | Disposed | 153901 | Direct |
| 2025-06-10 | Common Stock | S | 7310 | $88.29 | Disposed | 146591 | Direct |
| 2025-06-10 | Common Stock | S | 20926 | $88.99 | Disposed | 125665 | Direct |
| 2025-06-10 | Common Stock | S | 15825 | $89.85 | Disposed | 109840 | Direct |
| 2025-06-10 | Common Stock | S | 6328 | $90.93 | Disposed | 103512 | Direct |
| 2025-06-10 | Common Stock | S | 100 | $91.66 | Disposed | 103412 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-06-10 | Stock Option (right to buy) | $18.95 | M | 24150 | Disposed | 2033-05-11 | Common Stock (24150) | Direct |
| 2025-06-10 | Stock Option (right to buy) | $17.07 | M | 23740 | Disposed | 2032-05-11 | Common Stock (23740) | Direct |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 7,277 shares sold at prices ranging from $86.43 to $87.39 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 7,310 shares sold at prices ranging from $87.54 to $88.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 20,926 shares sold at prices ranging from $88.54 to $89.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: This is the weighted average sales price representing 15,825 shares sold at prices ranging from $89.54 to $90.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F6: This is the weighted average sales price representing 6,328 shares sold at prices ranging from $90.55 to $91.44 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F7: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.